≡

Recombinant Fibrinogen Like Protein 1 (FGL1)

FGL-1; HFREP1; HP-041; LFIRE1; Hepassocin; Hepatocyte-derived fibrinogen-related protein 1; Liver fibrinogen-related protein 1

  • Product No.RPD022Bo01
  • Organism SpeciesBos taurus; Bovine (Cattle) Same name, Different species.
  • SourceProkaryotic expression
  • HostE.coli
  • Endotoxin Level<1.0EU per 1µg (determined by the LAL method)
  • Subcellular LocationSecreted
  • Predicted Molecular Mass40.4kDa
  • Accurate Molecular Mass40/18kDa(Analysis of differences refer to the manual)
  • Residues & TagsLeu23~Val312 (Accession # Q3SZZ7) with N-terminal His Tag
  • Buffer FormulationPBS, pH7.4, containing 0.01% SKL, 5% Trehalose.
  • Traits Freeze-dried powder
  • Purity> 90%
  • Isoelectric Point5.96
  • Applications Positive Control; Immunogen; SDS-PAGE; WB.
    If bio-activity of the protein is needed, please check active protein.
  • DownloadInstruction Manual
  • UOM 10µg50µg 200µg 1mg 5mg
  • FOB US$ 168  US$ 420  US$ 840  US$ 2520  US$ 6300 
    For more details, please contact local distributors!

SEQUENCE

USAGE

Reconstitute in 10mM PBS (pH7.4) to a concentration of 0.1-1.0 mg/mL. Do not vortex.

STORAGE

Avoid repeated freeze/thaw cycles. Store at 2-8°C for one month. Aliquot and store at -80°C for 12 months.

STABILITY

The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37°C for 48h, and no obvious degradation and precipitation were observed. The loss rate is less than 5% within the expiration date under appropriate storage condition.

GIVEAWAYS

INCREMENT SERVICES

Magazine Citations
J Hepatol. The role of Hepassocin in the development of non-alcoholic fatty liver disease Pubmed: 23792031
Diabetes Management Serum hepassocin concentrations in diabetic patients with or without nonalcoholic fatty liver disease Futuremedicine:Source
United States Patent Application Compositions and Methods for Diagnosing Lung Cancer y2016:0077095.html
Cell Obesity Drives STAT-1-Dependent NASH and STAT-3-Dependent HCC Doi: 10.1016/j.cell.2018.09.053
Liver Research Do different bariatric surgery procedures impact hepassocin plasma levels in patients with type 2 diabetes mellitus?
Impacts of Different Modes of Bariatric Surgery on Plasma Levels of Hepassocin in Patients with Diabetes Mellitus
Catalog No. Related products for research use of Bos taurus; Bovine (Cattle) Organism species Applications (RESEARCH USE ONLY!)
RPD022Bo01 Recombinant Fibrinogen Like Protein 1 (FGL1) Positive Control; Immunogen; SDS-PAGE; WB.
PAD022Bo01 Polyclonal Antibody to Fibrinogen Like Protein 1 (FGL1) WB; IHC; ICC; IP.
LAD022Bo71 Biotin-Linked Polyclonal Antibody to Fibrinogen Like Protein 1 (FGL1) WB; IHC; ICC.